-$0.03 Earnings Per Share Expected for Castlight Health Inc (CSLT) This Quarter

Equities research analysts expect Castlight Health Inc (NYSE:CSLT) to post earnings of ($0.03) per share for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Castlight Health’s earnings, with the lowest EPS estimate coming in at ($0.04) and the highest estimate coming in at ($0.02). Castlight Health posted earnings of ($0.05) per share in the same quarter last year, which would indicate a positive year over year growth rate of 40%. The business is expected to issue its next earnings results on Wednesday, October 24th.

On average, analysts expect that Castlight Health will report full year earnings of ($0.13) per share for the current fiscal year, with EPS estimates ranging from ($0.15) to ($0.12). For the next financial year, analysts forecast that the business will post earnings of $0.01 per share, with EPS estimates ranging from ($0.03) to $0.04. Zacks’ EPS averages are an average based on a survey of research analysts that follow Castlight Health.

Castlight Health (NYSE:CSLT) last posted its earnings results on Monday, July 30th. The software maker reported ($0.09) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.09). Castlight Health had a negative net margin of 38.02% and a negative return on equity of 22.89%. The company had revenue of $37.70 million during the quarter, compared to analysts’ expectations of $36.85 million. During the same quarter in the previous year, the company posted ($0.07) earnings per share. Castlight Health’s quarterly revenue was up 15.6% compared to the same quarter last year.

A number of research analysts have recently issued reports on the stock. Cantor Fitzgerald reiterated a “buy” rating and issued a $5.00 target price on shares of Castlight Health in a research note on Friday, August 17th. Canaccord Genuity cut their target price on shares of Castlight Health from $7.00 to $6.00 and set a “buy” rating for the company in a research note on Tuesday, July 31st. Chardan Capital cut shares of Castlight Health from a “buy” rating to a “neutral” rating and cut their target price for the company from $6.00 to $4.80 in a research note on Tuesday, July 31st. ValuEngine cut shares of Castlight Health from a “buy” rating to a “hold” rating in a research note on Monday, July 30th. Finally, Dougherty & Co lifted their target price on shares of Castlight Health from $6.00 to $7.00 and gave the company a “buy” rating in a research note on Monday, July 23rd. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and five have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $5.56.

Shares of NYSE:CSLT traded down $0.05 during trading on Monday, reaching $2.49. The stock had a trading volume of 266,400 shares, compared to its average volume of 564,237. Castlight Health has a 52 week low of $2.41 and a 52 week high of $5.95. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.02. The stock has a market capitalization of $371.95 million, a P/E ratio of -9.85 and a beta of 1.15.

In related news, Director Seth B. Cohen sold 25,000 shares of the business’s stock in a transaction that occurred on Monday, July 23rd. The shares were sold at an average price of $5.47, for a total value of $136,750.00. Following the completion of the transaction, the director now owns 297,716 shares in the company, valued at approximately $1,628,506.52. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Mangini Siobhan Nolan sold 5,619 shares of the business’s stock in a transaction that occurred on Friday, July 20th. The stock was sold at an average price of $5.18, for a total transaction of $29,106.42. Following the completion of the transaction, the chief financial officer now owns 141,109 shares of the company’s stock, valued at approximately $730,944.62. The disclosure for this sale can be found here. Insiders sold a total of 66,433 shares of company stock valued at $330,141 in the last 90 days. 22.58% of the stock is currently owned by corporate insiders.

Several institutional investors have recently modified their holdings of the business. Northern Trust Corp raised its position in shares of Castlight Health by 22.9% during the 2nd quarter. Northern Trust Corp now owns 903,558 shares of the software maker’s stock valued at $3,840,000 after acquiring an additional 168,609 shares during the last quarter. GMT Capital Corp bought a new stake in shares of Castlight Health during the 2nd quarter valued at $2,990,000. Millennium Management LLC bought a new stake in shares of Castlight Health during the 2nd quarter valued at $891,000. MetLife Investment Advisors LLC bought a new stake in shares of Castlight Health during the 2nd quarter valued at $170,000. Finally, Metropolitan Life Insurance Co. NY bought a new stake in shares of Castlight Health during the 2nd quarter valued at $120,000. Institutional investors own 49.84% of the company’s stock.

About Castlight Health

Castlight Health, Inc provides a software-as-a-service platform used for health benefits navigation for employees in the United States. Its platform matches employees to the resources their employers make available to them; managing a condition; and assists them to manage their benefits. The company also offers communication and testing, implementation, and user customer support services.

Featured Article: How to interpret a stock’s beta number

Get a free copy of the Zacks research report on Castlight Health (CSLT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply